Evaluating Fatty Acid Amide Hydrolase as a Suitable Target for Sleep Promotion in a Transgenic TauP301S Mouse Model of Neurodegeneration

• Hauptverfasser: Shenée C. Martin (Verfasst von), Kathryn K. Joyce (Verfasst von), Kathryn M. Harper (Verfasst von), Samuel J. Harp (Verfasst von), Todd J. Cohen (Verfasst von), Sheryl S. Moy (Verfasst von), Graham H. Diering (Verfasst von)
• Format: Buch
• Veröffentlicht: MDPI AG, 2024-02-01T00:00:00Z.
• Schlagworte: article
• Online-Zugang: Connect to this object online.

Sleep disruption is an expected component of aging and neurodegenerative conditions, including Alzheimer's disease (AD). Sleep disruption has been demonstrated as a driver of AD pathology and cognitive decline. Therefore, treatments designed to maintain sleep may be effective in slowing or halt...